Supraventricular Tachycardias
3
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
3 treatments under study, led by Singlesyringe Adenosine
Research Leaders
5 sponsors active, led by Catholic University of the Sacred Heart
Related Conditions
Often studied with 7 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
67%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (3)
Comparison of Single-syringe vs. Double-syringe Techniques for Adenosine Administration in PSVT
Electrophysiological Registry Duesseldorf
Radiation Exposure Reduction in Supraventricular Tachycardia Ablation
Research Network
Common Treatments
- Singlesyringe Adenosine1
- Double Syringe Adenosine1
- Radiofrequency Catheter Ablation1
Active Sponsors
- Catholic University of the Sacred Heart1
- Heinrich-Heine University, Duesseldorf1
- Hormozgan University of Medical Sciences1
- Abbott Medical Devices1
- CNR Institute of Clinical Physiology, Pisa, Italy1
Top Investigators
Division of Cardiology, Pulmonary Disease and Vascular Medicine at University Hospital Duesseldorf
Cardiac Arrhythmia Research Centre, Centro Cardiologico Monzino, University of Milan, Milan, Italy
Division of Cardiology, Pulmonary Disease and Vascular Medicine at University Hospital Duesseldorf
Related Conditions
- Atrial Fibrillation Af1
- Supraventricular Arrhythmia1
- Svt1
- Atrial Flutter1
- Psvt1